DyAnsys in the News

Drug Relief wearable device
Una empresa suiza anuncia la aprobación de un dispositivo médico ponible por parte de la FDA para tratar la drogadicción

GINEBRA, 12 de junio de 2018 /PRNewswire/ -- DyAnsys Europe SARL ha anunciado que su empresa matriz, DyAnsys Inc., cuenta con la aprobación de la Administración de Alimentos y Medicamentos de los Estados Unidos (FDA) para un dispositivo de neuroestimulación auricular que trata los síntomas del...

Read More
FDA Clears DyAnsys Wearable Device to Treat Opioid Addiction without Narcotics

San Mateo, Ca -- DyAnsys Inc. announced that the U.S. Food and Drug Administration has cleared its auricular neurostimulation device, Drug Relief®, to be used as an aid to reduce the symptoms of opioid withdrawal without narcotics.

 

Drug Relief® is available now for providers to...

Read More
Advanced Medical Diagnostic and Monitoring Systems
Advanced Medical Diagnostic and Monitoring Systems

Interview conducted by:
Lynn Fosse, Senior Editor, CEOCFO Magazine, Published – June 29, 2015

CEOCFO: Mr. Nageshwar, what is the concept behind DyAnsys?
Mr. Nageshwar: We established the company based on measuring medical...

Read More
New DyAnsys® Inc. Solution Relieves Long-term Chronic Pain without Narcotics

San Francisco, CA – Chronic pain sufferers may find relief with a new, safe and effective non-narcotic treatment solution released by medical device maker DyAnsys, Inc. The company announced today that the four-piece system will be available in select doctors’ offices and pain management centers...

Read More
In the news
In the news

DyAnsys' Primary Relief® device provides neurostimulation therapy. The DyAnsys Primary Relief® monitor provides objective, scientific monitoring to improve P-stim therapy and enhance the opportunity for managing pain.

Read More

RSS

Email Us

Call Us